MD4458B1 - Use of Polybiolin drug in patients with liver cirrhosis - Google Patents
Use of Polybiolin drug in patients with liver cirrhosisInfo
- Publication number
- MD4458B1 MD4458B1 MDA20150017A MD20150017A MD4458B1 MD 4458 B1 MD4458 B1 MD 4458B1 MD A20150017 A MDA20150017 A MD A20150017A MD 20150017 A MD20150017 A MD 20150017A MD 4458 B1 MD4458 B1 MD 4458B1
- Authority
- MD
- Moldova
- Prior art keywords
- drug
- polybiolin
- patients
- liver cirrhosis
- dose
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to medicine, namely to the use of Polybiolin drug in patients with liver cirrhosis, wherein the drug is administered intramuscularly, in a dose of 500 mg, for 8…10 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20150017A MD4458C1 (en) | 2014-06-19 | 2014-06-19 | Use of Polybiolin drug in patients with liver cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20150017A MD4458C1 (en) | 2014-06-19 | 2014-06-19 | Use of Polybiolin drug in patients with liver cirrhosis |
Publications (3)
Publication Number | Publication Date |
---|---|
MD20150017A2 MD20150017A2 (en) | 2016-04-30 |
MD4458B1 true MD4458B1 (en) | 2017-01-31 |
MD4458C1 MD4458C1 (en) | 2017-08-31 |
Family
ID=55911138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20150017A MD4458C1 (en) | 2014-06-19 | 2014-06-19 | Use of Polybiolin drug in patients with liver cirrhosis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4458C1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0827742A1 (en) * | 1996-09-04 | 1998-03-11 | Vrije Universiteit Brussel | Use of histone deacetylase inhibitors for treating fribosis or cirrhosis |
MD1780G2 (en) * | 2001-02-02 | 2002-05-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method of treatment of patients with hepatic cirrhosis |
DE102005025906A1 (en) * | 2005-06-06 | 2006-12-07 | Dorian Bevec | Use of a guanylhydrazone compound in the manufacture of medicament for the treatment and/or prevention of e.g. acute and chronic hepatitis, liver cirrhosis, liver cell carcinoma, myocarditis, pharyngitis, pneumonia and pericarditis |
DE102005059750A1 (en) * | 2005-12-09 | 2007-06-14 | Salama, Zoser Boulis, Dr. | Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis |
FR2952826B1 (en) * | 2009-11-20 | 2012-04-06 | Lab Francais Du Fractionnement | USE OF MULTIPURPOSE IMMUNOGLOBULINS FOR TREATING ALCOHOLIC OR METABOLIC HEPATIC CIRRHOSIS |
MD4317C1 (en) * | 2013-09-12 | 2015-08-31 | Георге АНГЕЛИЧ | Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure |
-
2014
- 2014-06-19 MD MDA20150017A patent/MD4458C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD20150017A2 (en) | 2016-04-30 |
MD4458C1 (en) | 2017-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
JO3784B1 (en) | Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer | |
PH12016502352A1 (en) | Pharmaceutical composition | |
TW201613578A (en) | Pharmaceutical combinations | |
ECSP16084317A (en) | PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE | |
MX2017003780A (en) | Pharmaceutical composition for treating ulcerative colitis. | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
PH12017500617A1 (en) | Dosage regimen for pegylated interferon | |
MD4763B1 (en) | Pharmaceutical composition | |
MX2018006631A (en) | Compound for use in the prevention and treatment of neurodegenerative diseases. | |
MD4458B1 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
TW201613600A (en) | Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically | |
MD4317C1 (en) | Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating patients with advanced liver cirrhosis associated with heart failure | |
UA95834U (en) | Method for treating acute ischemic stroke | |
EA201892708A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMARATE FOR ADMINISTRATION IN A LOW DAILY DOSE | |
IN2014DE00822A (en) | ||
MD4231C1 (en) | Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis | |
MD4316B1 (en) | Use of 3-(2,2,2-trimethylhydrazinium)propionate dihydrate for treating portal gastropathies in patients with liver cirrhosis | |
UA91605U (en) | Method for correcting disordered microcirculation in gastric mucosa of aged patients | |
IN2014DE00818A (en) | ||
PH12014000105A1 (en) | Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds | |
MD4232B1 (en) | Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure | |
UA85352U (en) | Pharmaceutical composition containing nalbufin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |